When was Boston Heart Diagnostics founded?

Boston Heart Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Boston Heart Diagnostics located?

Boston Heart Diagnostics is headquartered in Framingham, United States.

How many employees does Boston Heart Diagnostics have?

As of Aug 31, 2026, the latest employee count at Boston Heart Diagnostics is 149.

Is Boston Heart Diagnostics a funded company?

Boston Heart Diagnostics is a funded company, having raised a total of $10.3M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 23, 2009.

When was the latest funding round of Boston Heart Diagnostics?

Boston Heart Diagnostics' latest funding was a $***** Series C round on Aug 09, 2010, with participation from 1 investor.

Where does Boston Heart Diagnostics rank among its competitors?

Boston Heart Diagnostics ranks 10th amongst 86 active competitors, of which 24 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was SmartHealth, which secured $300K in Nov, 2024.

Who are the top competitors of Boston Heart Diagnostics?

Boston Heart Diagnostics' top competitors include GEN inCode, Proxim Diagnostics and SmartHealth. Among them, SmartHealth secured the most recent funding round in November, 2024.

Boston Heart Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Boston Heart Diagnostics is an acquired company based in Framingham (United States), founded in 2007 by Bela Asztalos and Ernst Schaefer. It operates as a Developer of diagnosis for personalized care for cardiovascular diseases. Boston Heart Diagnostics has raised $10.3M in funding from Bain Capital Ventures. The company has 86 active competitors, including 24 funded and 18 that have exited. Its top competitors include companies like GEN inCode, Proxim Diagnostics and SmartHealth.

Company Details

Developer of diagnosis for personalized care for cardiovascular diseases. The company offers a combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.

Website: bostonheartdiagnostics.com
Social

Key Metrics

Founded Year

2007

Location

Framingham, United States

Stage

Acquired

Total Funding

$10.3M in 2 rounds

Latest Funding Round

Series C, Aug 09, 2010, $*****

Investors

Bain Capital Ventures & 10 more

Ranked

10^th among 86 active competitors

Employee Count

149 as on Aug 31, 2026

Similar Companies

GEN inCode & 113 more

Exit Details

Acquired by Eurofins Scientific (Dec 08, 2014)

View Boston Heart Diagnostics' full profile

Boston Heart Diagnostics got acquired by Eurofins Scientific on Dec 08, 2014 at an acquisition amount of $*****.

Click here to take a look at Boston Heart Diagnostics's acquisition in detail

Boston Heart Diagnostics has raised a total funding of $10.3M over 2 rounds. Its first funding round was on Mar 23, 2009. Its latest funding round was a Series C round on Aug 09, 2010 for $*****. 1 investor participated in its latest round. Boston Heart Diagnostics has 11 institutional investors.

Here is the list of recent funding rounds of Boston Heart Diagnostics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 09, 2010	8806530	Series C	9409142	6420458	1339076	4227532
Mar 23, 2009	7356636	Seed	9658379	5200361	4663310	6424055

Access funding benchmarks and valuations. Sign up today!

View details of Boston Heart Diagnostics's funding rounds and investors

The founders of Boston Heart Diagnostics are Bela Asztalos and Ernst Schaefer.

Here are the details of Boston Heart Diagnostics' key team members:

Bela Asztalos: Co-Founder & CSO of Boston Heart Diagnostics.
Ernst Schaefer: Founder of Boston Heart Diagnostics.
Susan Hertzberg: ex-CEO of Boston Heart Diagnostics.
Contact Info: 1 email address

View details of Boston Heart Diagnostics's Founder profiles and Board Members

Boston Heart Diagnostics' employee count trend

Boston Heart Diagnostics has 149 employees as of Aug 26. Here is Boston Heart Diagnostics's employee count trend over the years:

Employee count trend for Boston Heart Diagnostics

Uncover Boston Heart Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Boston Heart Diagnostics include GEN inCode, Proxim Diagnostics and SmartHealth. Here is the list of Top 10 competitors of Boston Heart Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GEN inCode 2018, Manchester (United Kingdom), Public	Developer of precison medicines by combining genetic and clinical data for cardiac disease monitoring	$5.46M	Downing, Maven Capital Partners & 4 others	57/100
2nd	Proxim Diagnostics 2010, Sunnyvale (United States), Series B	Developer of a handheld immunodiagnostic device for cardiac vascular diseases	$22.9M	BioMerieux, UCLA Ventures & 1 others	52/100
3rd	SmartHealth 1979, Irvine (United States), Series B	Developer precision diagnostics for vascular, metabolic, and oncological diseases	$17.3M	-	49/100
4th	Realview Imaging 2008, Yokneam Illit (Israel), Series C	Provides 3D holographic display based solutions for medical imaging applications	$25M	OurCrowd, ADIP & 10 others	49/100
5th	Zora Biosciences 2016, Espoo (Finland), Funding Raised	Provider of diagnostic solutions for cardiovascular diseases and cancer	-	Europa, Voima Ventures	46/100
6th	Epsilon Imaging 2008, Ann Arbor (United States), Series B	Advanced echo analysis software solutions improving cardiovascular care and workflow	$4.63M	ID Ventures, Michigan Angel Fund & 5 others	46/100
7th	Diadexus 1997, San Francisco (United States), Acquired	Innovating clinical diagnostics with advanced enzyme and immunoassay technologies	$49.2M	Brookside Capital, Burrill and Company & 4 others	45/100
8th	Prolight Diagnostics 2000, Lund (Sweden), Public	Provider of Point-of-Care systems for in-vitro diagnostic tests from a drop of blood	-	-	44/100
9th	Magnisense 2003, Paris (France), Series A	Develops emergency diagnostic tests for cardiovascular diseases	$11.5M	Noshaq, Concorde & 1 others	39/100
10th	Boston Heart Diagnostics 2007, Framingham (United States), Acquired	Developer of diagnosis for personalized care for cardiovascular diseases	$10.3M	Silversmith Capital Partners, DataPoint Ventures ... & 9 others	39/100